Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
December 15, 2021updated 03 Jan 2022 8:51am

The Middle East has seen the largest growth in infectious disease related trials over the past decade

We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.

By Saywah Mahmood

The Middle East has seen an 888% increase in the number of infectious disease trials taking place over the past decade, the largest increase for any region worldwide.

The region now ranks in first for the total number of trials taking place, compared to its sixth-placed ranking in 2010.

These figures come from GlobalData’s extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.

Middle East

The Middle East saw the biggest increase in infectious disease related trials.

Between 2010 and 2020, there was a 888% increase in the number of trials taking place.

Content from our partners
The importance of reference products in biosimilar trials, and how to source them
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

In 2020, the largest proportion of trials in the region took place in Iran with 79.3% of all trials in the region taking place there.

Israel and Saudi Arabia had the next largest percentage of trials taking place in the region with 9.1% and 3.4%, respectively.

Asia-Pacific

The Asia-Pacific region saw a 236% increase in the number of infectious disease trials taking place.

China saw the largest amount of trials taking place, in 2020, at 43.5%.

Trials in India and Australia also made up a large proportion of the trials taking place with 24.6% and 5.6%, respectively.

South and Central America

South and Central America saw a 212% increase in the number trials taking place.

Brazil, Argentina and Colombia made up the most trials in the region, with 45.9%, 14.9% and 9.7%, respectively.

Africa

Africa saw a 114% increase in infectious disease related trials taking place.

Egypt saw the largest percentage of trials taking place in the region at 24.7%.

South Africa and Uganda also made up a significant proportion of the trials taking place.

North America

Despite being placed fifth, North America still saw an increase in the number of infectious disease trials.

The region saw a 104% increase in the number of trials.

The United States made up 78.3% the largest proportion of trials taking place in the region.

Canada and Mexico also made up a large amount of the trials taking place with 11.7% and 10%, respectively.

Europe

Europe saw the biggest decrease in infectious disease trials.

The number of trials in the region fell by 97% between 2010 and 2020.

Spain saw the largest percentage of trials taking place in the region with 14.9%.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU